Mawer Investment Management Ltd. lowered its stake in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 14.2% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 305,036 shares of the technology company’s stock after selling 50,353 shares during the quarter. Mawer Investment Management Ltd. owned approximately 0.19% of Veeva Systems worth $87,073,000 as of its most recent SEC filing.
Other large investors have also added to or reduced their stakes in the company. Investment Research & Advisory Group Inc. grew its stake in shares of Veeva Systems by 0.4% during the 3rd quarter. Investment Research & Advisory Group Inc. now owns 12,942 shares of the technology company’s stock worth $3,699,000 after acquiring an additional 51 shares during the period. Chicago Partners Investment Group LLC boosted its position in Veeva Systems by 0.9% during the third quarter. Chicago Partners Investment Group LLC now owns 5,972 shares of the technology company’s stock worth $1,929,000 after purchasing an additional 55 shares during the period. Lodestone Wealth Management LLC boosted its position in Veeva Systems by 68.3% during the third quarter. Lodestone Wealth Management LLC now owns 138 shares of the technology company’s stock worth $39,000 after purchasing an additional 56 shares during the period. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors boosted its position in Veeva Systems by 1.2% during the third quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 4,664 shares of the technology company’s stock worth $1,331,000 after purchasing an additional 57 shares during the period. Finally, Ashton Thomas Private Wealth LLC increased its stake in shares of Veeva Systems by 4.9% in the third quarter. Ashton Thomas Private Wealth LLC now owns 1,212 shares of the technology company’s stock worth $346,000 after purchasing an additional 57 shares in the last quarter. Hedge funds and other institutional investors own 88.20% of the company’s stock.
Veeva Systems Stock Down 0.3%
NYSE:VEEV traded down $0.93 during trading hours on Friday, hitting $301.49. 750,106 shares of the company’s stock traded hands, compared to its average volume of 1,425,373. Veeva Systems Inc. has a 52 week low of $148.05 and a 52 week high of $325.99. The business’s fifty day simple moving average is $291.52 and its two-hundred day simple moving average is $214.01. The firm has a market cap of $48.81 billion, a P/E ratio of 49.59, a P/E/G ratio of 1.29 and a beta of 0.89.
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $2.23 by $0.12. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%. The business had revenue of $927.96 million for the quarter, compared to analyst estimates of $905.38 million. During the same period in the prior year, the company earned $1.99 EPS. The company’s quarterly revenue was up 17.6% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, analysts expect that Veeva Systems Inc. will post 6.70 EPS for the current year.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on VEEV. Barclays upped their price target on shares of Veeva Systems from $360.00 to $375.00 and gave the company an “overweight” rating in a research note on Wednesday, October 28th. Weiss Ratings upgraded shares of Veeva Systems from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Canaccord Genuity Group boosted their target price on shares of Veeva Systems from $260.00 to $315.00 and gave the company a “hold” rating in a report on Monday, November 9th. Wall Street Zen upgraded Veeva Systems from a “hold” rating to a “buy” rating in a research report on Saturday, October 10th. Finally, Guggenheim increased their target price on Veeva Systems from $276.00 to $310.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $317.42.
View Our Latest Analysis on Veeva Systems
Insiders Place Their Bets
In related news, insider Thomas Schwenger sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $281.33, for a total value of $2,813,300.00. Following the transaction, the insider directly owned 19,449 shares in the company, valued at approximately $5,471,587.17. This represents a 33.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Jonathan Faddis sold 5,198 shares of the firm’s stock in a transaction that occurred on Wednesday, October 14th. The shares were sold at an average price of $299.72, for a total transaction of $1,557,944.56. Following the completion of the sale, the senior vice president directly owned 4,130 shares in the company, valued at $1,237,843.60. This represents a 55.72% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 20,789 shares of company stock worth $5,905,609 over the last three months. Company insiders own 10.60% of the company’s stock.
Veeva Systems Company Profile
Veeva Systems Inc. develops cloud-based software, data and consulting services for the life sciences industry. Its customers include pharmaceutical and biotechnology companies, medical device makers and contract research organizations. The company’s products support commercial operations as well as clinical, regulatory, quality and safety activities. Its offerings include Veeva Vault applications for managing documents and business processes, customer relationship management software, and data and analytics services.
See Also
- Five stocks we like better than Veeva Systems
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
